Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin β-4 in the dystrophin deficient mouse

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Spurney, Christopher F ^a   Cha, Hee Jae ^b   Sali, Arpana ^a   Pandey, Gouri S ^a   Pistilli, Emidio ^c   Guerron, Alfredo D ^a   Gordish Dressman, Heather ^a   Hoffman, Eric P ^a   Nagaraju, Kanneboyina ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b Kosin University College of Medicine   (South Korea)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; THYMOSIN BETA4; THYMOSIN; THYMOSIN BETA(4);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; GRIP STRENGTH; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; MOUSE; MUSCLE FUNCTION; MUSCLE REGENERATION; MYOFIBROSIS; NONHUMAN; PROTEIN LOCALIZATION; SKELETAL MUSCLE; STAINING; ANIMAL; C57BL MOUSE; GENETICS; HEART; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; DYSTROPHIN; FEMALE; HEART; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; THYMOSIN;

EID: 77952471877     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008976     Document Type: Article

References (40)

1. Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928.
2. Ryder-Cook AS, Sicinski P, Thomas K, Davies KE, Worton RG, et al. (1988) Localization of the mdx mutation within the mouse dystrophin gene. EMBO J 7: 3017-3021.
3. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, et al. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244: 1578-1580.
4. Anderson JE, Bressler BH, Ovalle WK (1988) Functional regeneration in the hindlimb skeletal muscle of the mdx mouse. J Muscle Res Cell Motil 9: 499-515.
5. De Luca A, Pierno S, Liantonio A, Cetrone M, Camerino C, et al. (2003) Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1. J Pharmacol Exp Ther 304: 453-463.
6. Lefaucheur JP, Pastoret C, Sebille A (1995) Phenotype of dystrophinopathy in old mdx mice. Anat Rec 242: 70-76.
7. Quinlan JG, Hahn HS, Wong BL, Lorenz JN, Wenisch AS, et al. (2004) Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul Disord 14: 491-496.
8. Spurney CF, Knoblach S, Pistilli EE, Nagaraju K, Martin GR, et al. (2008) Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart. Neuromuscul Disord 18: 371-381.
9. Boer JM, de Meijer EJ, Mank EM, van Ommen GB, den Dunnen JT (2002) Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mdx mice. Neuromuscul Disord 12 Suppl 1: S118-124.
10. Marotta M, Ruiz-Roig C, Sarria Y, Peiro JL, Nunez F, et al. (2009) Muscle genome-wide expression profiling during disease evolution in mdx mice. Physiol Genomics 37: 119-132.
11. Nakayama Y, Nara N, Kawakita Y, Takeshima Y, Arakawa M, et al. (2004) Cloning of cDNA encoding a regeneration-associated muscle protease whose expression is attenuated in cell lines derived from Duchenne muscular dystrophy patients. Am J Pathol 164: 1773-1782.
12. Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, et al. (2002) A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 11: 263-272.
13. Porter JD, Merriam AP, Leahy P, Gong B, Feuerman J, et al. (2004) Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Hum Mol Genet 13: 257-269.
14. Porter JD, Merriam AP, Leahy P, Gong B, Khanna S (2003) Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. Hum Mol Genet 12: 1813-1821.
15. Rouger K, Le Cunff M, Steenman M, Potier MC, Gibelin N, et al. (2002) Global/temporal gene expression in diaphragm and hindlimb muscles of dystrophin-deficient (mdx) mice. Am J Physiol Cell Physiol 283: C773-784.
16. Tseng BS, Zhao P, Pattison JS, Gordon SE, Granchelli JA, et al. (2002) Regenerated mdx mouse skeletal muscle shows differential mRNA expression. J Appl Physiol 93: 537-545.
17. Turk R, Sterrenburg E, de Meijer EJ, van Ommen GJ, den Dunnen JT, et al. (2005) Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling. BMC Genomics 6: 98.
18. Hara T, Nakayama Y, Nara N (2005) [Regenerative medicine of skeletal muscle]. Rinsho Shinkeigaku 45: 880-882.
19. Oates K, Goldstein A (1995) Thymosin. In: DeVita VT, Hellman S, Rosenberg SA, eds (1995) Biologic Therapy of Cancer. Philadelphia: JB Lippincott. pp 841-852.
20. Pantaloni D, Carlier MF (1993) How profilin promotes actin filament assembly in the presence of thymosin beta 4. Cell 75: 1007-1014.
21. Weber A, Nachmias VT, Pennise CR, Pring M, Safer D (1992) Interaction of thymosin beta 4 with muscle and platelet actin: implications for actin sequestration in resting platelets. Biochemistry 31: 6179-6185.
22. Hannappel E, Huff T (2003) The thymosins. Prothymosin alpha, parathymosin, and beta-thymosins: structure and function. Vitam Horm 66: 257-296.
23. Safer D, Elzinga M, Nachmias VT (1991) Thymosin beta 4 and Fx, an actinsequestering peptide, are indistinguishable. J Biol Chem 266: 4029-4032.
24. Safer D, Golla R, Nachmias VT (1990) Isolation of a 5-kilodalton actinsequestering peptide from human blood platelets. Proc Natl Acad Sci U S A 87: 2536-2540.
25. Sanders MC, Goldstein AL, Wang YL (1992) Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc Natl Acad Sci U S A 89: 4678-4682.
26. Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, et al. (1999) Thymosin beta4 accelerates wound healing. J Invest Dermatol 113: 364-368.
27. Sosne G, Szliter EA, Barrett R, Kernacki KA, Kleinman H, et al. (2002) Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res 74: 293-299.
28. Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D (2004) Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432: 466-472.
29. Spurney CF, Gordish-Dressman H, Guerron AD, Sali A, Pandey GS, et al. (2009) Preclinical drug trials in the mdx mouse: Assessment of reliable and sensitive outcome measures. Muscle Nerve 39: 591-602.
30. Tietz N (1982) Fundamentals of clinical chemistry. Philadelphia: WB Saunders Co. pp 682-689.
31. Philp D, Nguyen M, Scheremeta B, St-Surin S, Villa AM, et al. (2004) Thymosin beta4 increases hair growth by activation of hair follicle stem cells. FASEB J 18: 385-387.
32. Sosne G, Qiu P, Christopherson PL, Wheater MK (2007) Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway. Exp Eye Res 84: 663-669.
33. Sosne G, Siddiqi A, Kurpakus-Wheater M (2004) Thymosin-beta4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro. Invest Ophthalmol Vis Sci 45: 1095-1100.
34. Baudy AR, Saxena N, Gordish H, Hoffman EP, Nagaraju K (2009) A robust in vitro screening assay to identify NF-kappaB inhibitors for inflammatory muscle diseases. Int Immunopharmacol 9: 1209-1214.
35. Sosne G, Chan CC, Thai K, Kennedy M, Szliter EA, et al. (2001) Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp Eye Res 72: 605-608.
36. Reti R, Kwon E, Qiu P, Wheater M, Sosne G (2008) Thymosin beta4 is cytoprotective in human gingival fibroblasts. Eur J Oral Sci 116: 424-430.
37. Zhang Y, Feurino LW, Zhai Q, Wang H, Fisher WE, et al. (2008) Thymosin Beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation. Cancer Biol Ther 7: 419-423.
38. Cavasin MA, Liao TD, Yang XP, Yang JJ, Carretero OA (2007) Decreased endogenous levels of Ac-SDKP promote organ fibrosis. Hypertension 50: 130-136.
39. Pokharel S, van Geel PP, Sharma UC, Cleutjens JP, Bohnemeier H, et al. (2004) Increased myocardial collagen content in transgenic rats overexpressing cardiac angiotensin-converting enzyme is related to enhanced breakdown of N-acetyl-Ser-Asp-Lys-Pro and increased phosphorylation of Smad2/3. Circulation 110: 3129-3135.
40. Mora CA, Baumann CA, Paino JE, Goldstein AL, Badamchian M (1997) Biodistribution of synthetic thymosin beta 4 in the serum, urine, and major organs of mice. Int J Immunopharmacol 19: 1-8.